Published: 19 December 2018
Author(s): Nuria Vicente-Ibarra, Francisco Marín, Vicente Pernías-Escrig, Miriam Sandín-Rollán, Laura Núñez-Martínez, Teresa Lozano, Manuel Jesús Macías-Villaniego, Luna Carrillo-Alemán, Elena Candela-Sánchez, Elena Guzmán, María Asunción Esteve-Pastor, Esteban Orenes-Piñero, Mariano Valdés, José Miguel Rivera-Caravaca, Juan M. Ruiz-Nodar
Section: Original Article
Anemia is frequent in acute coronary syndrome (ACS) patients and is associated with worse clinical outcomes. We aimed to investigate the therapeutic strategies, the use of novel P2Y12 inhibitors, and the prognostic implication of anemia in a “real world” cohort of ACS patients.
